SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
AMRX

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)

US · Delayed Price · Currency is USD
Healthcare · Drug Manufacturers - Specialty & Generic
21.05+0.68 (+3.31%)
 
Market cap
$6.72B
Analyst consensus
Listed since
May 7, 2018
Website
Insider Score
––Not scored
AMRX Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

AMRX Stock Insider Trading Activity

AMRX stock’s insider trading shows 5 sales on the open market for an estimated $7.67M by company insiders over the last 6 months.

Not enough price history.

Insider Trading Activity (Form 4 Filings)

An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.

Scored window · last 90 days0 qualifying buys0 insiders$0 bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
InsiderActionSharesAvg CostTotalΔ HoldingsHeld AfterDateGradeForm 4
BUCHI J KEVIN
Director
Gift20,445—— 21.4%75,077Sep 17, 2026— Form 4
BUCHI J KEVIN
Director
Option exercise20,445$14.45$295.43K 27.2%95,522Sep 11, 2026— Form 4
BOYER ANDREW S
Other
Gift80,000—— 29.2%193,646Sep 1, 2026— Form 4
BOYER ANDREW S
Other
Gift152,426—— 35.8%273,646Aug 21, 2026— Form 4
Kiely John
Director
Gift10,000—— 4.8%200,252Aug 13, 2026— Form 4
Kiely John
Director
Sell50,000$17.64$882.00K 19.2%210,252Aug 13, 2026— Form 4
Shah Nikita
Other
Sell146,403$17.51$2.56M 36.6%253,390Aug 12, 2026— Form 4
Daly Jason B.
Other
Sell210,000$17.40$3.65M 85.7%35,171Aug 12, 2026— Form 4
Daly Jason B.
Other
Sell6,613$17.70$117.05K 2.6%245,171Aug 11, 2026— Form 4
BUCHI J KEVIN
Director
Option exercise168,573$17.18$2.90M 64.3%93,499Aug 11, 2026— Form 4
Patel Chintu
CEO
Award6,381,734—— New6,381,734Aug 10, 2026— Form 4
Patel Chirag K.
CEO
Award6,381,734—— New6,381,734Aug 10, 2026— Form 4
Patel Gautam
Director
Award283,632—— New283,632Aug 10, 2026— Form 4
Patel Tushar Bhikhubhai
Other
Award12,763,469—— 26.3%61,341,678Aug 10, 2026— Form 4
Autor Deborah M.
Director
Sell34,819$12.94$450.56K 27.1%93,660May 11, 2026— Form 4
Patel Gautam
Director
Option exercise34,819—— 2.2%1,643,963May 7, 2026— Form 4
George Jeffrey P.
Director
Option exercise34,819—— 11.2%344,614May 7, 2026— Form 4
Kiely John
Director
Option exercise34,819—— 15.4%260,252May 7, 2026— Form 4
Nark Ted C
Director
Option exercise34,819—— 12.0%325,848May 7, 2026— Form 4
MEISTER PAUL M
Director
Option exercise48,747—— 6.2%832,800May 7, 2026— Form 4
Yanai Shlomo
Director
Option exercise34,819—— 12.2%320,804May 7, 2026— Form 4
Autor Deborah M.
Director
Option exercise34,819—— 37.2%128,479May 7, 2026— Form 4
BUCHI J KEVIN
Director
Option exercise34,819—— 86.5%75,077May 7, 2026— Form 4
Konidaris Tasos
CFO
Tax withheld22,035$13.30$293.07K 4.7%449,434Mar 4, 2026— Form 4
Daly Jason B.
Other
Tax withheld15,580$13.30$207.21K 5.8%251,784Mar 4, 2026— Form 4
Daly Jason B.
Other
Option exercise35,880—— 15.5%267,364Mar 4, 2026— Form 4
Patel Chirag K.
CEO
Option exercise92,593—— 6.9%1,431,295Mar 4, 2026— Form 4
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
  • Sell (S) — Open-market or private sale
  • Award (A) — Grant or award from the company, not a purchase
  • Tax withheld (F) — Shares withheld to pay tax or an exercise price
  • Option exercise (M) — Exercise or conversion of an exempt derivative
  • Gift (G) — Bona fide gift
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.